| Opella Healthcare Switzerland AG - Telfast 180, Filmtabletten | | 54204 | | 03 | | Telfast 180 | | Filmtabletten | | R06AX26 | | Fexofenadin | | 26.06.1997 | | |
| | Composition | | fexofenadini hydrochloridum 180 mg, cellulosum microcristallinum, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 0.18 mg, magnesii stearas, Überzug: hypromellosum, polyvidonum K 29-32, E 171, silica colloidalis anhydrica, macrogolum 400, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | | | | | | Principe actif | Concentr. |
|---|
| Fexofénadine Hydrochloride | 180 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Fexofénadine Hydrochloride | 180 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | | | | | | | | | | | | | | | color. | | | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | | | | | | 29-32 | | | | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
